Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Tff Pharmaceuticals, Inc. (TFFP) since 2019 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Tff Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1733413.
Total stock buying since 2019: $5,256,276.
Total stock sales since 2019: $34,986,934.
Total stock option exercises since 2019: $1,618,253.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 1,010,000 | $369,045 | 216,000 | $94,347 | 0 | $0 |
| 2022 | 725,360 | $4,345,462 | 120,765 | $518,079 | 120,765 | $301,911 |
| 2021 | 11,000 | $78,300 | 948,406 | $14,175,539 | 233,406 | $608,522 |
| 2020 | 54,081 | $298,469 | 1,416,128 | $20,198,969 | 283,128 | $707,820 |
| 2019 | 33,000 | $165,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-08 | 820,000 | $205,000 | 216,000 | $94,347 | 0 | $0 |
| 2023-03 | 190,000 | $164,045 | 0 | $0 | 0 | $0 |
| 2022-11 | 43,470 | $49,990 | 0 | $0 | 0 | $0 |
| 2022-09 | 0 | $0 | 120,765 | $518,079 | 120,765 | $301,911 |
| 2022-05 | 139,890 | $685,752 | 0 | $0 | 0 | $0 |
| 2022-04 | 542,000 | $3,609,720 | 0 | $0 | 0 | $0 |
| 2021-09 | 11,000 | $78,300 | 0 | $0 | 0 | $0 |
| 2021-03 | 0 | $0 | 790,006 | $11,284,351 | 75,006 | $212,522 |
| 2021-02 | 0 | $0 | 45,700 | $771,012 | 45,700 | $114,250 |
| 2021-01 | 0 | $0 | 112,700 | $2,120,176 | 112,700 | $281,750 |
| 2020-12 | 0 | $0 | 1,137,794 | $15,889,486 | 87,794 | $219,485 |
| 2020-11 | 5,000 | $75,655 | 275,334 | $4,258,483 | 195,334 | $488,335 |
| 2020-09 | 0 | $0 | 3,000 | $51,000 | 0 | $0 |
| 2020-05 | 20,000 | $101,600 | 0 | $0 | 0 | $0 |
| 2020-04 | 29,081 | $121,214 | 0 | $0 | 0 | $0 |
| 2019-10 | 33,000 | $165,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-08-16 | Carlson Clint Duane (10% Owner) | Sale | 1,000 | .39 | 392 |
| 2023-08-15 | Mikhak Zamaneh (Chief Medical Officer) | Buy | 120,000 | .25 | 30,000 |
| 2023-08-15 | Coleman Kirk Allen (Chief Financial Officer) | Buy | 20,000 | .25 | 5,000 |
| 2023-08-15 | Weisman Harlan F (President and CEO) | Buy | 600,000 | .25 | 150,000 |
| 2023-08-15 | Roberts Brandi | Buy | 20,000 | .25 | 5,000 |
| 2023-08-15 | Carlson Clint Duane (10% Owner) | Sale | 215,000 | .44 | 93,955 |
| 2023-08-15 | Mills Robert S | Buy | 40,000 | .25 | 10,000 |
| 2023-08-15 | Rocamboli Stephen | Buy | 20,000 | .25 | 5,000 |
| 2023-03-10 | Mikhak Zamaneh (Chief Medical Officer) | Buy | 15,000 | .82 | 12,300 |
| 2023-03-10 | Coleman Kirk Allen (Chief Financial Officer) | Buy | 12,000 | .79 | 9,456 |
| 2023-03-10 | Weisman Harlan F (President and CEO) | Buy | 150,000 | .88 | 131,850 |
| 2023-03-10 | Rocamboli Stephen | Buy | 13,000 | .80 | 10,439 |
| 2022-11-22 | Fletcher Aaron G.l. | Buy | 43,470 | 1.15 | 49,990 |
| 2022-09-29 | Thurman Randy H | Sale | 80,510 | 4.29 | 345,386 |
| 2022-09-29 | Thurman Randy H | Option Ex | 80,510 | 2.50 | 201,274 |
| 2022-05-20 | Weisman Harlan F | Buy | 4,615 | 5.50 | 25,382 |
| 2022-05-18 | Weisman Harlan F | Buy | 2,500 | 5.12 | 12,800 |
| 2022-05-17 | Coleman Kirk Allen (Chief Financial Officer) | Buy | 425 | 4.83 | 2,052 |
| 2022-05-17 | Fletcher Aaron G.l. | Buy | 24,600 | 5.08 | 124,968 |
| 2022-05-16 | Coleman Kirk Allen (Chief Financial Officer) | Buy | 1,250 | 4.40 | 5,500 |
| 2022-05-16 | Fletcher Aaron G.l. | Buy | 85,000 | 4.86 | 413,100 |
| 2022-05-16 | Mattes Glenn R. (President and CEO) | Buy | 16,000 | 4.78 | 76,480 |
| 2022-05-16 | Weisman Harlan F | Buy | 2,500 | 4.74 | 11,850 |
| 2022-05-16 | Rocamboli Stephen | Buy | 3,000 | 4.54 | 13,620 |
| 2022-04-04 | Fletcher Aaron G.l. | Buy | 542,000 | 6.66 | 3,609,720 |
| 2021-09-16 | Coleman Kirk Allen (CFO, Secretary and Treasurer) | Buy | 1,000 | 7.30 | 7,300 |
| 2021-09-16 | Mattes Glenn R. (President and CEO) | Buy | 10,000 | 7.10 | 71,000 |
| 2021-03-26 | Lung Therapeutics, Inc. | Sale | 715,000 | 14.00 | 10,010,000 |
| 2021-03-15 | Coleman Kirk Allen (CFO, Secretary and Treasurer) | Sale | 5,000 | 17.05 | 85,250 |
| 2021-03-15 | Coleman Kirk Allen (CFO, Secretary and Treasurer) | Option Ex | 5,000 | 2.50 | 12,500 |
| 2021-03-15 | Mattes Glenn R. (President and CEO) | Sale | 50,000 | 17.04 | 852,000 |
| 2021-03-15 | Mattes Glenn R. (President and CEO) | Option Ex | 50,000 | 2.50 | 125,000 |
| 2021-03-15 | Rocamboli Stephen | Sale | 20,006 | 16.85 | 337,101 |
| 2021-03-15 | Rocamboli Stephen | Option Ex | 20,006 | 3.75 | 75,022 |
| 2021-02-16 | Coleman Kirk Allen (CFO, Secretary and Treasurer) | Sale | 5,000 | 16.82 | 84,100 |
| 2021-02-16 | Coleman Kirk Allen (CFO, Secretary and Treasurer) | Option Ex | 5,000 | 2.50 | 12,500 |
| 2021-02-16 | Mattes Glenn R. (President and CEO) | Sale | 40,000 | 16.82 | 672,800 |
| 2021-02-16 | Mattes Glenn R. (President and CEO) | Option Ex | 40,000 | 2.50 | 100,000 |
| 2021-02-10 | Mills Robert S | Sale | 700 | 20.16 | 14,112 |
| 2021-02-10 | Mills Robert S | Option Ex | 700 | 2.50 | 1,750 |
| 2021-01-20 | Mills Robert S | Sale | 12,600 | 20.20 | 254,520 |
| 2021-01-20 | Mills Robert S | Option Ex | 12,600 | 2.50 | 31,500 |
| 2021-01-19 | Mills Robert S | Sale | 55,100 | 19.56 | 1,077,756 |
| 2021-01-19 | Mills Robert S | Option Ex | 55,100 | 2.50 | 137,750 |
| 2021-01-15 | Coleman Kirk Allen (CFO, Secretary and Treasurer) | Sale | 5,000 | 17.50 | 87,500 |
| 2021-01-15 | Coleman Kirk Allen (CFO, Secretary and Treasurer) | Option Ex | 5,000 | 2.50 | 12,500 |
| 2021-01-15 | Mattes Glenn R. (President and CEO) | Sale | 40,000 | 17.51 | 700,400 |
| 2021-01-15 | Mattes Glenn R. (President and CEO) | Option Ex | 40,000 | 2.50 | 100,000 |
| 2020-12-23 | Coleman Kirk Allen (CFO, Secretary and Treasurer) | Sale | 10,000 | 15.24 | 152,400 |
| 2020-12-23 | Coleman Kirk Allen (CFO, Secretary and Treasurer) | Option Ex | 10,000 | 2.50 | 25,000 |
| 2020-12-23 | Mattes Glenn R. (President and CEO) | Sale | 30,000 | 15.33 | 459,900 |
| 2020-12-23 | Mattes Glenn R. (President and CEO) | Option Ex | 30,000 | 2.50 | 75,000 |
| 2020-12-11 | Mills Robert S | Sale | 22,794 | 14.58 | 332,336 |
| 2020-12-11 | Mills Robert S | Option Ex | 22,794 | 2.50 | 56,985 |
| 2020-12-07 | Windsor James Brian (Chief Science Officer) | Sale | 25,000 | 15.80 | 395,000 |
| 2020-12-07 | Windsor James Brian (Chief Science Officer) | Option Ex | 25,000 | 2.50 | 62,500 |
| 2020-12-04 | Lung Therapeutics, Inc. | Sale | 1,050,000 | 13.86 | 14,549,850 |
| 2020-11-24 | Fletcher Aaron G.l. | Buy | 5,000 | 15.13 | 75,655 |
| 2020-11-13 | Thurman Randy H | Sale | 5,000 | 17.17 | 85,864 |
| 2020-11-12 | Fairbairn Malcolm | Sale | 11,669 | 15.97 | 186,307 |
| 2020-11-11 | Fairbairn Malcolm | Sale | 63,331 | 15.93 | 1,008,926 |
| 2020-11-11 | Rocamboli Stephen | Sale | 15,722 | 15.76 | 247,731 |
| 2020-11-11 | Rocamboli Stephen | Option Ex | 15,722 | 2.50 | 39,305 |
| 2020-11-11 | Thurman Randy H | Sale | 34,504 | 15.91 | 548,889 |
| 2020-11-11 | Thurman Randy H | Option Ex | 34,504 | 2.50 | 86,260 |
| 2020-11-10 | Coleman Kirk Allen (CFO, Secretary, and Treasurer) | Sale | 15,000 | 15.12 | 226,755 |
| 2020-11-10 | Coleman Kirk Allen (CFO, Secretary, and Treasurer) | Option Ex | 15,000 | 2.50 | 37,500 |
| 2020-11-10 | Mattes Glenn R. (President and CEO) | Sale | 108,830 | 14.99 | 1,631,905 |
| 2020-11-10 | Mattes Glenn R. (President and CEO) | Option Ex | 108,830 | 2.50 | 272,075 |
| 2020-11-10 | Rocamboli Stephen | Sale | 21,278 | 15.14 | 322,106 |
| 2020-11-10 | Rocamboli Stephen | Option Ex | 21,278 | 2.50 | 53,195 |
| 2020-09-25 | Mattes Glenn R. (President and CEO) | Sale | 3,000 | 17.00 | 51,000 |
| 2020-05-26 | Fletcher Aaron G.l. | Buy | 20,000 | 5.08 | 101,600 |
| 2020-04-15 | Fletcher Aaron G.l. | Buy | 5,581 | 4.72 | 26,342 |
| 2020-04-06 | Fletcher Aaron G.l. | Buy | 6,252 | 4.24 | 26,508 |
| 2020-04-03 | Fletcher Aaron G.l. | Buy | 16,748 | 3.97 | 66,489 |
| 2020-04-02 | Fletcher Aaron G.l. | Buy | 500 | 3.75 | 1,875 |
| 2019-10-25 | Windsor James Brian (Chief Science Officer) | Buy | 5,000 | 5.00 | 25,000 |
| 2019-10-25 | Coleman Kirk Allen (CFO, Secretary, and Treasurer) | Buy | 1,000 | 5.00 | 5,000 |
| 2019-10-25 | Fletcher Aaron G.l. | Buy | 2,000 | 5.00 | 10,000 |
| 2019-10-25 | Mattes Glenn R. (President and CEO) | Buy | 10,000 | 5.00 | 50,000 |
| 2019-10-25 | Weisman Harlan F | Buy | 5,000 | 5.00 | 25,000 |
| 2019-10-25 | Mills Robert S | Buy | 5,000 | 5.00 | 25,000 |
| 2019-10-25 | Thurman Randy H | Buy | 5,000 | 5.00 | 25,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of TFFP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Tff Pharmaceuticals, Inc. (symbol TFFP, CIK number 1733413) see the Securities and Exchange Commission (SEC) website.